Loading...
XSWX
MOVE
Market cap2.63bUSD
Apr 04, Last price  
113.80CHF
1D
-6.87%
1Q
3.27%
IPO
15.71%
Name

Medacta Group SA

Chart & Performance

D1W1MN
No data to show
P/E
50.73
P/S
4.70
EPS
2.38
Div Yield, %
0.48%
Shrs. gr., 5y
-0.05%
Rev. gr., 5y
13.38%
Revenues
511m
+16.85%
219,051,000244,683,000272,610,000310,623,000302,492,000363,126,000437,122,000510,778,000
Net income
47m
+2.41%
39,219,00033,496,00045,753,00011,859,00037,091,00051,521,00046,249,00047,362,000
CFO
75m
+2.20%
56,313,00051,586,00066,408,00042,635,00059,592,00054,061,00073,510,00075,127,000
Dividend
May 10, 20240.55 CHF/sh
Earnings
May 07, 2025

Profile

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Europe, North America, the Asia-Pacific, and internationally. It offers personalized kinematic models and 3D planning tools for use in hip, knee, shoulder, sports medicine, and spine procedures. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.
URL
http://www.medacta.com/
IPO date
Apr 04, 2019
Employees
1,537
Domiciled in
CH
Incorporated in
CH

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
510,778
16.85%
437,122
20.38%
Cost of revenue
435,721
368,304
Unusual Expense (Income)
NOPBT
75,057
68,818
NOPBT Margin
14.69%
15.74%
Operating Taxes
11,364
8,543
Tax Rate
15.14%
12.41%
NOPAT
63,693
60,275
Net income
47,362
2.41%
46,249
-10.23%
Dividends
(11,054)
(10,418)
Dividend yield
0.44%
0.51%
Proceeds from repurchase of equity
(3,911)
42,388
BB yield
0.16%
-2.06%
Debt
Debt current
55,034
12,981
Long-term debt
187,697
165,325
Deferred revenue
92,973
Other long-term liabilities
69,467
(137,592)
Net debt
221,939
(55,207)
Cash flow
Cash from operating activities
75,127
73,510
CAPEX
(71,239)
(63,158)
Cash from investing activities
(80,606)
(65,106)
Cash from financing activities
(10,130)
3,438
FCF
(50,554)
(13,231)
Balance
Cash
20,792
32,261
Long term investments
201,252
Excess cash
211,657
Stockholders' equity
327,617
258,637
Invested Capital
601,484
242,709
ROIC
15.09%
26.84%
ROCE
12.48%
13.79%
EV
Common stock shares outstanding
19,952
19,996
Price
125.60
21.94%
103.00
-27.46%
Market cap
2,505,964
21.67%
2,059,584
-27.49%
EV
2,727,903
2,004,377
EBITDA
132,708
111,945
EV/EBITDA
20.56
17.91
Interest
6,830
3,663
Interest/NOPBT
9.10%
5.32%